Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients.

BACKGROUND AND OBJECTIVES Billing claims are increasingly examined beyond administrative functions as outcomes measures in observational research. Few studies have described the performance of billing claims as surrogate measures of clinical events among kidney transplant recipients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS We investigated the sensitivity of Medicare billing claims for clinically verified cardiovascular diagnoses (five categories) and procedures (four categories) in a novel database linking Medicare claims to electronic medical records of one transplant program. Cardiovascular events identified in medical records for 571 Medicare-insured transplant recipients in 1991 through 2002 served as reference measures. RESULTS Within a claims-ascertainment period spanning +/-30 d of clinically recorded dates, aggregate sensitivity of single claims was higher for case definitions incorporating Medicare Parts A and B for diagnoses and procedures (90.9%) compared with either Part A (82.3%) or Part B (84.6%) alone. Perfect capture of the four procedures was possible within +/-30 d or with short claims window expansion, but sensitivity for the diagnoses trended lower with all study algorithms (91.2% with window up to +/-90 d). Requirement for additional confirmatory diagnosis claims did not appreciably reduce sensitivity. Sensitivity patterns were similar in the early compared with late periods of the study. CONCLUSIONS Combined use of Medicare Parts A and B billing claims composes a sensitive measure of cardiovascular events after kidney transplant. Further research is needed to define algorithms that maximize specificity as well as sensitivity of claims from Medicare and other insurers as research measures in this population.

[1]  Bruce Kaplan,et al.  Reliability of Medicare claim forms for outcome studies in kidney transplant recipients: epidemiology in clinical outcome trials. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[2]  A. Zaslavsky,et al.  Quality of care in for-profit and not-for-profit health plans enrolling Medicare beneficiaries. , 2005, The American journal of medicine.

[3]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[4]  M. Schnitzler,et al.  Incidence and predictors of myocardial infarction after kidney transplantation. , 2005, Journal of the American Society of Nephrology : JASN.

[5]  L. Agodoa,et al.  Early renal insufficiency and late venous thromboembolism after renal transplantation in the United States. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  B. Kasiske,et al.  Peripheral arterial disease and renal transplantation. , 2006, Journal of the American Society of Nephrology : JASN.

[7]  L. Agodoa,et al.  Late urinary tract infection after renal transplantation in the United States. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  L L Roos,et al.  Estimating the burden of disease. Comparing administrative data and self-reports. , 1997, Medical care.

[9]  J. Pavlin,et al.  Evaluation of ICD-9 codes for syndromic surveillance in the electronic surveillance system for the early notification of community-based epidemics. , 2007, Military medicine.

[10]  M. Schnitzler,et al.  Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus. , 2004, Journal of the American Society of Nephrology : JASN.

[11]  B. Kasiske,et al.  Cancer after Kidney Transplantation in the United States , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  B. Kasiske,et al.  Cardiovascular disease after renal transplantation. , 2000, Journal of the American Society of Nephrology : JASN.

[13]  B. B. Fleming,et al.  Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levels. , 2000, JAMA.

[14]  M. Schnitzler,et al.  Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[15]  H. Tunstall-Pedoe,et al.  Definitions for Acute Coronary Heart Disease in Epidemiology and Clinical Research Studies , 2003 .

[16]  B. Yawn,et al.  Identifying Persons with Diabetes Using Medicare Claims Data , 1999, American journal of medical quality : the official journal of the American College of Medical Quality.

[17]  M. Schnitzler,et al.  Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[18]  R S Woodward,et al.  ECONOMIC COST OF EXPANDED CRITERIA DONORS IN CADAVERIC RENAL TRANSPLANTATION: ANALYSIS OF MEDICARE PAYMENTS1 , 2000, Transplantation.

[19]  B. Kasiske,et al.  Acute myocardial infarction and kidney transplantation. , 2006, Journal of the American Society of Nephrology : JASN.

[20]  B. Kasiske,et al.  Depressive disorder in renal transplantation: an analysis of Medicare claims. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  B. Kasiske,et al.  Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. , 2000, Journal of the American Society of Nephrology : JASN.

[22]  Donald R. Miller,et al.  Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. , 2004, Diabetes care.

[23]  Allen J. Taylor,et al.  Hospitalized congestive heart failure after renal transplantation in the United States. , 2002, Annals of epidemiology.

[24]  M. Schnitzler Diabetes Mellitus After Kidney Transplantation in the United States , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  John G.F. Cleland,et al.  [Guidelines for the Diagnosis and Treatment of Chronic Heart Failure: executive summary (update 2005)]. , 2005, Revista espanola de cardiologia.

[26]  Sebastian Schneeweiss,et al.  Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. , 2004, American heart journal.

[27]  M. Schnitzler,et al.  De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  M. Kuske,et al.  Assignment1 of the human PHLDA1 gene to chromosome 12q15 by radiation hybrid mapping , 2000, Cytogenetic and Genome Research.

[29]  M. Schnitzler,et al.  Novel methods for tracking long-term maintenance immunosuppression regimens. , 2008, Clinical journal of the American Society of Nephrology : CJASN.